Inhalation
Sessions D1 & D2

Return to Program Page

Session D1 (Sunday, 0900-1200)  Salon 15
Session Chair: G. Hochhaus

0900 -  17. J. Weers; Hollow porous particles for inhalation therapy
0945 -  18. L.R. Brown; ProMaxx protein microspheres for pulmonary and injectable drug delivery
1015 - Break
1030 -  19. R. Price; Use of AFM to elucidate humidity induced changes in interparticle adhesion in dry powder inhaler systems
1100 -  20. W. Watanabe; Drug particle engineering via aerosol synthesis
1130 -  21. P. Stewart; How does the carrier particle size distribution affect the dispersion of drugs from interactive mixtures
1200 - End of Session

Return to Program Page

Session D2 (Sunday, 1400-1700)  Salon 15
Session Chair: J. Weers

1400 -  50. G. Hochhaus; Approaches to slow release pulmonary drug delivery
1445 -  51. P.G. Rogueda; Inhalation particles interactions in fluorinated liquids
1515 - Break
1530 -  52. J.S. Kaerger; Novel production of respirable sized particles by electrohydrodynamic atomization
1545 -  53. D.A.V. Morton; Gas-phase aerosol synthesis of an additive material for enhancing dry powder inhaler formulation performance
1600 -  54. H. Gill; Hollow porous particles in metered dose iInhalers
1630 -  55. M.J. Asmus; In vitro particle deposition predicts bioavailability of inhaled fluticasone in children with asthma
1700 - End of Session

Return to Program Page
To Top of Page

(C)  2002  Particles Conference